Detecting risk and predicting patient mortality in patients with extended-spectrum β-lactamase-producingEnterobacteriaceaebloodstream infections
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Detecting risk and predicting patient mortality in patients with extended-spectrum β-lactamase-producingEnterobacteriaceaebloodstream infections
Authors
Keywords
-
Journal
Future Microbiology
Volume 7, Issue 10, Pages 1173-1189
Publisher
Future Medicine Ltd
Online
2012-10-03
DOI
10.2217/fmb.12.100
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Carbapenem Therapy for Bacteremia Due to Extended-Spectrum-β-Lactamase-Producing Escherichia coli or Klebsiella pneumoniae: Implications of Ertapenem Susceptibility
- (2012) Nan-Yao Lee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multidrug-Resistant Proteus mirabilis Bloodstream Infections: Risk Factors and Outcomes
- (2012) Mario Tumbarello et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Klebsiella ESBL bacteremia-mortality and risk factors
- (2012) Felipe Francisco Tuon et al. Brazilian Journal of Infectious Diseases
- Time to positivity of blood culture association with clinical presentation, prognosis and ESBL-production in Escherichia coli bacteremia
- (2012) R. Álvarez et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Bloodstream infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care hospital in New Zealand: risk factors and outcomes
- (2012) Joshua T. Freeman et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis
- (2012) Wouter C. Rottier et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Molecular Analysis and Risk Factors for Escherichia coli Producing Extended-Spectrum β-Lactamase Bloodstream Infection in Hematological Malignancies
- (2012) Patricia Cornejo-Juárez et al. PLoS One
- Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy
- (2011) Cheol-In Kang et al. ANNALS OF HEMATOLOGY
- Identifying Patients Harboring Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae on Hospital Admission: Derivation and Validation of a Scoring System
- (2011) Mario Tumbarello et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Risk factors for bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae
- (2011) Olivia Ferrández Quirante et al. Brazilian Journal of Infectious Diseases
- -Lactam/ -Lactam Inhibitor Combinations for the Treatment of Bacteremia Due to Extended-Spectrum -Lactamase-Producing Escherichia coli: A Post Hoc Analysis of Prospective Cohorts
- (2011) J. Rodriguez-Bano et al. CLINICAL INFECTIOUS DISEASES
- Clinical manifestations and prognostic factors in cancer patients with bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae
- (2011) Shu-Shen Wang et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Emergence of Extended-Spectrum β-Lactamase-Producing Escherichia coli as a Cause of Community-Onset Bacteremia in South Korea: Risk Factors and Clinical Outcomes
- (2011) Sun Hee Park et al. Microbial Drug Resistance
- Bacteremia Due to Extended-Spectrum- -Lactamase-Producing Enterobacter cloacae: Role of Carbapenem Therapy
- (2010) C.-C. Lee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- National Multicenter Study of Predictors and Outcomes of Bacteremia upon Hospital Admission Caused by Enterobacteriaceae Producing Extended-Spectrum -Lactamases
- (2010) D. Marchaim et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Costs of Bloodstream Infections Caused by Escherichia coli and Influence of Extended-Spectrum- -Lactamase Production and Inadequate Initial Antibiotic Therapy
- (2010) M. Tumbarello et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Infections with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae
- (2010) Johann D.D. Pitout DRUGS
- Risk factors and outcomes of Escherichia coli bacteremia caused by strains that produce CTX-M or non-CTX-M extended-spectrum-beta-lactamases
- (2010) U.-I. Wu et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum β-lactamase-producing Escherichia coli
- (2010) Cheol-In Kang et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Risk factors and outcome of extended-spectrum β-lactamase-producing Enterobacter cloacae bloodstream infections
- (2010) Zubair A. Qureshi et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Risk Factors and Prognosis of Nosocomial Bloodstream Infections Caused by Extended-Spectrum- -Lactamase-Producing Escherichia coli
- (2010) J. Rodriguez-Bano et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Risk Factors for Bloodstream Infections due to Extended-spectrum β-lactamase-producing Escherichia coli
- (2010) Un-In Wu et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Risk factors for and mortality of extended-spectrum-β-lactamase-producing Klebsiella pneumoniae and Escherichia coli nosocomial bloodstream infections
- (2010) Silvana Vargas Superti et al. REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO
- Community‐Onset Bacteremia Due to Extended‐Spectrum β‐Lactamase–ProducingEscherichia coli:Risk Factors and Prognosis
- (2009) Jesús Rodríguez‐Baño et al. CLINICAL INFECTIOUS DISEASES
- Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome
- (2009) M. Ortega et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Incidence and clinical impact of extended-spectrum-β-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies
- (2009) Enrico M. Trecarichi et al. JOURNAL OF INFECTION
- Bloodstream Infections Caused by Extended-Spectrum- -Lactamase- Producing Escherichia coli: Risk Factors for Inadequate Initial Antimicrobial Therapy
- (2008) M. Tumbarello et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Extended-spectrum β-lactamases in long-term-care facilities
- (2008) Marie-Hélène Nicolas-Chanoine et al. CLINICAL MICROBIOLOGY AND INFECTION
- Clinical significance of extended-spectrum β-lactamases
- (2008) Jesús Rodríguez-Baño et al. Expert Review of Anti-Infective Therapy
- Clinical and Molecular Epidemiology of Healthcare-Associated Infections Due to Extended-Spectrum β-Lactamase (ESBL)–Producing Strains of Escherichia coli and Klebsiella pneumoniae That Harbor Multiple ESBL Genes
- (2008) Anucha Apisarnthanarak et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Predictors of Mortality From Community-Onset Bloodstream Infections Due to Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae
- (2008) Anucha Apisarnthanarak et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Molecular epidemiology and risk factors of bloodstream infections caused by extended-spectrum β-lactamase-producing Klebsiella pneumoniae
- (2008) Juan L. Mosqueda-Gómez et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- The effect of control group selection in the analysis of risk factors for extended spectrum β-lactamase-producing Klebsiella pneumoniae infections. A prospective controlled study
- (2008) P.R.P. Behar et al. JOURNAL OF HOSPITAL INFECTION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search